Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7163)
All Articles published online
|
Publishing Process of This Article
|
Jul 21, 2022 (publication date) through May 13, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ueno M, Takeda H, Takai A, Seno H. Risk factors and diagnostic biomarkers for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: Current evidence and future perspectives. World J Gastroenterol 2022; 28(27): 3410-3421 [PMID: 36158261 DOI: 10.3748/wjg.v28.i27.3410] |
|---|---|
| URL: | https://www.wjgnet.com/2220-315x/full/v28/i27/3410.htm |
| Number | Citing Articles |
| 1 |
Farah Abdelhameed, Chris Kite, Lukasz Lagojda, Alexander Dallaway, Kamaljit Kaur Chatha, Surinderjeet S. Chaggar, Maria Dalamaga, Eva Kassi, Ioannis Kyrou, Harpal S. Randeva. Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD. Current Obesity Reports 2024; 13(3): 510 doi: 10.1007/s13679-024-00574-z
|
| 2 |
Jinlin Hou, Thomas Berg, Arndt Vogel, Teerha Piratvisuth, Jörg Trojan, Enrico N. De Toni, Masatoshi Kudo, Katarina Malinowsky, Peter Findeisen, Johannes Kolja Hegel, Wenzel Schöning, Kairat Madin, Konstantin Kroeniger, Henry Lik-Yuen Chan, Ashish Sharma. Comparative evaluation of multimarker algorithms for early-stage HCC detection in multicenter prospective studies. JHEP Reports 2025; 7(2): 101263 doi: 10.1016/j.jhepr.2024.101263
|
| 3 |
Kaleb Tesfai, Jordan Pace, Nora El-Newihi, Maria Elena Martinez, Monica A. Tincopa, Rohit Loomba. Disparities for Hispanic Adults With Metabolic Dysfunction-associated Steatotic Liver Disease in the United States: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 2025; 23(2): 236 doi: 10.1016/j.cgh.2024.06.038
|
| 4 |
Paul Wasuwanich, Joshua M. So, Mustafa Sadek, Chaowapong Jarasvaraparn, Songyos Rajborirug, Ruben E. Quiros-Tejeira, Wikrom Karnsakul. Pediatric Non-Alcoholic Fatty Liver Disease (NAFLD): Trends, Mortality, and Socioeconomic Disparities in the U.S., 1998–2020. Children 2025; 12(1): 71 doi: 10.3390/children12010071
|
| 5 |
Marina Montagnani Marelli, Chiara Macchi, Massimiliano Ruscica, Patrizia Sartori, Roberta Manuela Moretti. Anticancer Activity of Delta-Tocotrienol in Human Hepatocarcinoma: Involvement of Autophagy Induction. Cancers 2024; 16(15): 2654 doi: 10.3390/cancers16152654
|
| 6 |
Marlene Sophia Kohlhepp, Hanyang Liu, Frank Tacke, Adrien Guillot. The contradictory roles of macrophages in non-alcoholic fatty liver disease and primary liver cancer—Challenges and opportunities. Frontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1129831
|
| 7 |
Zhao Li, Lan Lan, Yujia Zhou, Ruoxing Li, Kenneth D. Chavin, Hua Xu, Liang Li, David J.H. Shih, W. Jim Zheng. Developing deep learning-based strategies to predict the risk of hepatocellular carcinoma among patients with nonalcoholic fatty liver disease from electronic health records. Journal of Biomedical Informatics 2024; 152: 104626 doi: 10.1016/j.jbi.2024.104626
|
| 8 |
Pojsakorn Danpanichkul, Yanfang Pang, Kanokphong Suparan, Thanida Auttapracha, Supapitch Sirimangklanurak, Abdelrahman M. Attia, Chanattha Thimphitthaya, Michelle Shi Ni Law, Zhenning Yu, Mostafa A. Soliman, Natchaya Polpichai, Chanakarn Kanitthamniyom, Donghee Kim, Mazen Noureddin, Amit G. Singal, Karn Wijarnpreecha, Ju Dong Yang. Increased MASH-associated liver cancer in younger demographics. Hepatology Communications 2025; 9(1) doi: 10.1097/HC9.0000000000000629
|
| 9 |
Carmelo Laface, Girolamo Ranieri, Felicia Maria Maselli, Francesca Ambrogio, Caterina Foti, Michele Ammendola, Marigia Laterza, Gerardo Cazzato, Riccardo Memeo, Giovanni Mastrandrea, Marco Lioce, Palma Fedele. Immunotherapy and the Combination with Targeted Therapies for Advanced Hepatocellular Carcinoma. Cancers 2023; 15(3): 654 doi: 10.3390/cancers15030654
|
| 10 |
Maria V. Bourganou, Maria Eleni Chondrogianni, Ioannis Kyrou, Christina-Maria Flessa, Antonios Chatzigeorgiou, Evangelos Oikonomou, Vaia Lambadiari, Harpal S. Randeva, Eva Kassi. Unraveling Metabolic Dysfunction-Associated Steatotic Liver Disease Through the Use of Omics Technologies. International Journal of Molecular Sciences 2025; 26(4): 1589 doi: 10.3390/ijms26041589
|
| 11 |
Hikaru Nakahara, Atsushi Ono, C. Nelson Hayes, Yuki Shirane, Ryoichi Miura, Yasutoshi Fujii, Yosuke Tamura, Shinsuke Uchikawa, Hatsue Fujino, Takashi Nakahara, Eisuke Murakami, Masami Yamauchi, Tomokazu Kawaoka, Daiki Miki, Masataka Tsuge, Tsuyoshi Kobayashi, Hideki Ohdan, Koji Arihiro, Shiro Oka. Multiomics Analysis of Liver Molecular Dysregulation Leading to Nonviral-Related Hepatocellular Carcinoma Development. Journal of Proteome Research 2025; 24(3): 1102 doi: 10.1021/acs.jproteome.4c00729
|
| 12 |
Han Li, Hui Liu, Lun-Jie Yan, Zi-Niu Ding, Xiao Zhang, Guo-Qiang Pan, Cheng-Long Han, Bao-Wen Tian, Si-Yu Tan, Zhao-Ru Dong, Dong-Xu Wang, Yu-Chuan Yan, Tao Li. Performance of GALAD score and serum biomarkers for detecting NAFLD-related HCC: a systematic review and network meta-analysis. Expert Review of Gastroenterology & Hepatology 2023; 17(11): 1159 doi: 10.1080/17474124.2023.2279175
|
| 13 |
Rana A. Youness, Hossam A. Hassan, Tasneem Abaza, Ahmed A. Hady, Hekmat M. El Magdoub, Mohamed Ali, Johannes Vogel, Markus Thiersch, Max Gassmann, Nadia M. Hamdy, Mostafa A. Aboouf. A Comprehensive Insight and In Silico Analysis of CircRNAs in Hepatocellular Carcinoma: A Step toward ncRNA-Based Precision Medicine. Cells 2024; 13(15): 1245 doi: 10.3390/cells13151245
|
| 14 |
Masayuki Ueno, Takahisa Kayahara, Hiroyuki Takabatake, Youichi Morimoto, Motowo Mizuno. Clinical characteristics and diagnostic process of nonalcoholic fatty liver disease-associated hepatocellular carcinoma. Kanzo 2023; 64(3): 122 doi: 10.2957/kanzo.64.122
|
| 15 |
Madalina-Gabriela Taru, Monica Lupsor-Platon. Exploring Opportunities to Enhance the Screening and Surveillance of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease (NAFLD) through Risk Stratification Algorithms Incorporating Ultrasound Elastography. Cancers 2023; 15(16): 4097 doi: 10.3390/cancers15164097
|
| 16 |
Kainan Zhang, Mengsi Yu, Hui Liu, Zhao Hui, Ning Yang, Xiaojuan Bi, Li Sun, RenYong Lin, Guodong Lü. Upregulated TUBG1 expression is correlated with poor prognosis in hepatocellular carcinoma. PeerJ 2022; 10: e14415 doi: 10.7717/peerj.14415
|
| 17 |
Jamie Klein, Ana Catalina Arce-Clachar, Kristin Bramlage, Stavra Xanthakos, Rachel Sheridan, Marialena Mouzaki. Elevated Alpha-Fetoprotein Levels in Children with Metabolic Dysfunction-Associated Liver Disease. Childhood Obesity 2025; doi: 10.1089/chi.2025.0010
|